SCHEMBL3662765

SCHEMBL3662765

COc1ccc2c(c1)CN(c1ccc3cccnc3c1)C2

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.43
RAB9A P51151 2/20 0.43
ALDH1A1 P00352 2/20 0.42
ALOX15 P16050 1/20 0.42
HTR6 P50406 3/20 0.42
MAPT P10636 3/20 0.42
ROCK2 O75116 1/20 0.42
P2RY14 Q15391 1/20 0.41
PDGFRB P09619 1/20 0.41
PDGFRA P16234 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
HTR1A P08908 1/20 0.41
DRD2 P14416 1/20 0.41
HTR2A P28223 1/20 0.41
HTR7 P34969 1/20 0.41
DRD3 P35462 1/20 0.41
KMT2A Q03164 1/20 0.41
TIPARP Q7Z3E1 2/20 0.40
CHRNA7 P36544 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3661215 0.90 CCKAR (0.44) NPC1RAB9AALDH1A1ALOX15MAPT
SCHEMBL3481281 0.78 NPC1 (0.51) NPC1RAB9AALDH1A1HTR6MAPT
SCHEMBL619653 0.78 RAB9A (0.59) NPC1RAB9AALDH1A1P2RY14PDGFRB
SCHEMBL29831778 0.78 RAB9A (0.59) NPC1RAB9AALDH1A1P2RY14PDGFRB
SCHEMBL29096117 0.76 PDGFRB (0.62) NPC1RAB9AALDH1A1P2RY14PDGFRB
Benzene SCHEMBL27716393 0.76 CYP3A4 (0.61) NPC1RAB9AALDH1A1P2RY14PDGFRB
SCHEMBL27645134 0.75 PDE3B (0.55) NPC1RAB9AALDH1A1ALOX15MAPT
SCHEMBL4221803 0.73 MEN1 (0.67) NPC1RAB9AALDH1A1MAPTCYP1A2
SCHEMBL3481646 0.72 PRMT5 (0.43) MAPTHTR1ADRD2DRD3TIPARP
SCHEMBL10567250 0.70 TERT (0.61) NPC1RAB9AALDH1A1CYP1A2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2215074-A1 ISOINDOLINE COMPOUNDS FOR THE TREATMENT OF SPINAL MUSCULAR ATROPHY AND OTHER USES The United States of America, as Represented by the Secretary, Department of Health and Human Services (US) 2010-08-11 EP disclosed
WO-2009042907-A1 ISOINDOLINE COMPOUNDS FOR THE TREATMENT OF SPINAL MUSCULAR ATROPHY AND OTHER USES THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2009-04-02 WO disclosed